97 related articles for article (PubMed ID: 1116868)
1. Studies on the inhibition of C56-initiated lysis (reactive lysis). III. Characterization of the inhibitory activity C567-INH and its mode of action.
McLeod B; Baker P; Gewurz H
Immunology; 1975 Jan; 28(1):133-49. PubMed ID: 1116868
[TBL] [Abstract][Full Text] [Related]
2. Studies of the inhibition of C56-initiated lysis (reactive lysis). IV. Antagonism of the inhibitory activity c567-INH by poly-L-lysine.
McLeod B; Baker P; Behrends C; Gewurz H
Immunology; 1975 Feb; 28(2):379-90. PubMed ID: 47309
[TBL] [Abstract][Full Text] [Related]
3. Studies on the inhibition of C56-initiated lysis (reactive lysis). V. The roleof C567-INH in the regulation of complement-dependent haemolysis initiated by cobravenom factor.
McLeod B; Lint TF; Baker P; Behrends C; Gewurz H
Immunology; 1975 Apr; 28(4):741-54. PubMed ID: 1171082
[TBL] [Abstract][Full Text] [Related]
4. Activation of the complement attack mechanism in the fluid phase and its control by C567-INH: lysis of normal erythrocytes initiated by zymosan, endotoxin, and immune complexes.
Lint TF; Behrends CL; Baker PJ; Gewurz H
J Immunol; 1976 Nov; 117(5 Pt 1):1440-6. PubMed ID: 1002985
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of C56-initiated lysis by leucocyte cationic proteins, myelin basic proteins and lysine-rich histones.
Baker PJ; Lint TF; Siegel J; Kies MW; Gewurz H
Immunology; 1976 Apr; 30(4):467-73. PubMed ID: 818007
[TBL] [Abstract][Full Text] [Related]
6. Studies on the inhibition of C56-initiated lysis (reactive lysis). II. C567-INH--an inhibitor of the C567 trimolecular complex of complement.
McLeod BC; Baker P; Gewurz H
Int Arch Allergy Appl Immunol; 1974; 47(4):623-32. PubMed ID: 4415956
[No Abstract] [Full Text] [Related]
7. Reaction mechanisms of nascent C567 (reactive lysis). I. Reaction characteristics for production of EC567 and lysis by C8 and C9.
Goldman JN; Ruddy S; Austen KF
J Immunol; 1972 Aug; 109(2):353-9. PubMed ID: 4558539
[No Abstract] [Full Text] [Related]
8. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
Rosenfeld SI; Jenkins DE; Leddy JP
J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
[TBL] [Abstract][Full Text] [Related]
9. Studies on the inhibition of C56-induced lysis (reactive lysis). VI. Modulation of C56-induced lysis polyanions and polycations.
Baker PJ; Lint TF; McLeod BC; Behrends CL; Gewurz H
J Immunol; 1975 Feb; 114(2 Pt 1):554-8. PubMed ID: 1168218
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of C56-initiated lysis by cell-bound C3 fragments: evidence for a mechanism independent of the prior binding of C56 to C3b.
Yamamoto KI; Lint TF; Gewurz H
J Immunol; 1977 Oct; 119(4):1346-50. PubMed ID: 894040
[TBL] [Abstract][Full Text] [Related]
11. C567-initiated cytolysis of lymphoid cells: description of the phenomenon and studies on its control by C567 inhibitors.
Baker PJ; Lint TF; Mortensen RF; Gewurz H
J Immunol; 1977 Jan; 118(1):198-202. PubMed ID: 830747
[TBL] [Abstract][Full Text] [Related]
12. Reactive lysis: the complement-mediated lysis of unsensitized cells. II. The characterization of activated reactor as C56 and the participation of C8 and C9.
Lachmann PJ; Thompson RA
J Exp Med; 1970 Apr; 131(4):643-57. PubMed ID: 4193935
[TBL] [Abstract][Full Text] [Related]
13. A factor in guinea-pig serum with accelerating effect on immune immobilization of Treponema pallidum (IAF). Isolation, purification and differentiation from the known haemolytic complement components and from lysozyme.
Müller F; Segerling M
Immunology; 1974 Jul; 27(1):33-41. PubMed ID: 4604004
[TBL] [Abstract][Full Text] [Related]
14. Reactions of nascent C567 (reactive lysis).
Goldman JN
Transplant Proc; 1974 Mar; 6(1):21-5. PubMed ID: 4817055
[No Abstract] [Full Text] [Related]
15. Resistance of sheep erythrocytes to immune lysis by treatment of the cells with a human erythrocyte extract: studies on the site of inhibition.
Hoffmann EM; Cheng WC; Tomeu EJ; Renk CM
J Immunol; 1974 Nov; 113(5):1501-9. PubMed ID: 4424275
[No Abstract] [Full Text] [Related]
16. Serum lipoproteins and C567-INH activity.
Lint TF; Behrends CL; Gewurz H
J Immunol; 1977 Sep; 119(3):883-8. PubMed ID: 561124
[No Abstract] [Full Text] [Related]
17. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
Rollins SA; Zhao J; Ninomiya H; Sims PJ
J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
[TBL] [Abstract][Full Text] [Related]
18. Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9.
Shin ML; Hänsch G; Hu VW; Nicholson-Weller A
J Immunol; 1986 Mar; 136(5):1777-82. PubMed ID: 2419414
[TBL] [Abstract][Full Text] [Related]
19. Isolation of erythrocyte membrane inhibitor of reactive lysis type II. Identification as glycophorin A.
Tomita A; Radike EL; Parker CJ
J Immunol; 1993 Sep; 151(6):3308-23. PubMed ID: 7690802
[TBL] [Abstract][Full Text] [Related]
20. Complement lysis of U937, a nucleated mammalian cell line in the absence of C9: effect of C9 on C5b-8 mediated cell lysis.
Morgan BP; Imagawa DK; Dankert JR; Ramm LE
J Immunol; 1986 May; 136(9):3402-6. PubMed ID: 3514758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
